SAN DIEGO, Oct. 21 /PRNewswire-FirstCall/ -- Cymer, Inc. (Nasdaq: CYMI), the world's leading supplier of light sources used by chipmakers to create advanced semiconductor chips, today announced operating results for the third quarter ended September 30, 2010.
(Logo: http://photos.prnewswire.com/prnh/20090406/LA94420LOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20090406/LA94420LOGO)
For the third quarter of 2010:
- net income totaled $20,881,000 equal to $0.70 per share (diluted), compared to net income of $10,785,000, equal to $0.36 per share (diluted) in the third quarter of 2009 and net income of $21,212,000, equal to $0.70 per share (diluted), in the second quarter of 2010.
- revenue totaled $141,710,000 compared to revenue of $92,328,000 in the third quarter of 2009, and revenue of $131,864,000 in the second quarter of 2010.
Commenting on third quarter results, Bob Akins, Cymer's chief executive officer, said, "We executed well during the quarter, delivering solid financial performance. Our Installed Base Products revenue continued to increase as pulse utilization remained high, the mix of ArF pulses increased, and the active installed base of light sources continued to grow. Combined sales of our deep ultraviolet (DUV) ArF immersion and KrF light sources rose as chipmakers continued their investment in technology and capacity additions in support of existing fab expansions and new fab build-outs." In addition, "We shipped a third extreme ultraviolet (EUV) 3100 source to ASML and are proceeding this quarter with the installation of our first 3100 source at a memory manufacturer," concluded Akins.
In the third quarter of 2010, the company shipped 35 light sources, of which 25 were ArF immersion and 10 were KrF, and installed 35 light sources at chipmaker locations. Gross profit was $68.5 million for the third quarter of 2010, yielding a 48.3 percent gross margin. Gross margin was below the company's July guidance primarily as a result of a higher than anticipated start-up expenditure made to bring on board 146 light sources to OnPulse coverage, and the installation of advanced performance enhancements on ArF immersion sources which are uniquely available under OnPulse. Total operating expenses, which include research and development and selling and administrative expenses, were $38.3 million. Total operating income was $30.2 million or 21.3 percent of revenue. The third quarter effective tax rate was 31 percent. As of September 30, 2010, cash and investments totaled $177.6 million.
Deep ultraviolet (DUV) bookings for the third quarter of 2010 totaled $143.4 million, resulting in a book-to-bill ratio of 1.01. Sixty six percent of the light source bookings in the third quarter were ArF immersion and 34 percent were KrF. The company ended the quarter with a DUV backlog of $57.3 million, with ArF immersion light sources comprising approximately 86 percent of the value of sources in backlog.
Company Outlook
Commenting on the outlook, Akins stated, "We are encouraged by our business outlook for the fourth quarter. We expect pulse utilization to be high and demand for our DUV light sources to increase. In the third and fourth quarter, we have been rewarded with future key selections from the memory sector in response to the demonstrated performance and reliability of our ArF and KrF sources, and the OnPulse advantage. We will continue our commitment to develop and commercialize our LPP EUV source technology, and our TCZ tool for next generation organic light emitting diode (OLED) panel display manufacturing."
Based on information available at this time, Cymer is providing the following guidance for the fourth quarter of 2010:
- Revenue to be in the range of $140 to $145 million.
- Gross margin to be approximately 49 percent.
- R&D expenses to be approximately $24 million.
- SG&A expenses to be approximately $16 million.
- The full year 2010 effective tax rate to be approximately 32 percent.
Cymer's management will hold a conference call at 2:00 pm (PDT) today, October 21, 2010, to discuss third quarter 2010 operating results and fourth quarter 2010 guidance. This press release, the conference call and accompanying slides may be accessed on the investor relations page of the company's Web site at www.cymer.com.
Forward Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to statements regarding the installation of an EUV 3100 source, the industry's transition to EUV lithography and the statements under the caption "Company Outlook" above. These statements are predictions based on current information and expectations and involve a number of risks and uncertainties. In addition, statements regarding backlog and book-to-bill ratios should not be read as predictions or projections of future performance. Actual events or results may differ materially from those projected in any of such statements due to various factors, including but not limited to: the demand for semiconductors in general, and, in particular, for leading-edge devices with smaller geometries; cyclicality in the market for semiconductor manufacturing equipment; the timing of customer orders, shipments and acceptances; delays or cancellations by customers of their orders; the performance and market acceptance of the company's new products or technologies; new and enhanced product offerings by competitors; the company's ability to meet its production and product development schedules; the rate at which semiconductor manufacturers adopt new technologies and purchase and take delivery of photolithography tools from the company's customers; the company's ability to secure adequate supplies of critical components for its advanced products; the company's ability to manage its expense levels and unanticipated expenses; the company's ability to achieve its forecasted gross margin which includes its ability to absorb manufacturing costs; the company's ability to align its cost structure with forecasted business levels; the company's ability to manage its foreign currency exposure; the performance and conditions in the United States and world financial markets; the policies and actions of the United States and other governments; and general economic conditions. For a discussion of these and other factors which may cause our actual events or results to differ from those projected, please refer to the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission (SEC). You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.
About Cymer
Cymer, Inc. (Nasdaq: CYMI) is the market leader in developing light sources, used by chipmakers worldwide to pattern advanced semiconductor chips, and is pioneering a new silicon crystallization tool for the flat panel display industry. Cymer's light sources have been widely adopted by the world's top chipmakers and the company's installed base comprises approximately 3,500 systems. Continuing its legacy of leadership, Cymer is currently pioneering the industry's transition to EUV lithography, the next viable step on the technology roadmap for the creation of smaller, faster chips. The company is headquartered in San Diego, Calif., and supports its customers from numerous offices around the globe. Cymer maintains a Web site to which it regularly posts press releases, SEC filings, and additional information about Cymer. Interested persons can also subscribe to automated e-mail alerts or RSS feeds. Please visit www.cymer.com.
Cymer and all other Cymer product or service names used herein are either registered trademarks or trademarks of Cymer, Inc. Any other marks mentioned herein are the property of their respective holders.
CYMER, INC. |
||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||
(in thousands, except per share data) |
||||||||
(unaudited) |
||||||||
Three Months Ended |
Nine Months Ended |
|||||||
September 30, |
September 30, |
|||||||
2010 |
2009 |
2010 |
2009 |
|||||
Revenues: |
||||||||
Product sales |
$141,710 |
$92,110 |
$387,355 |
$210,724 |
||||
Product sales - related party |
- |
218 |
- |
536 |
||||
Total revenues |
141,710 |
92,328 |
387,355 |
211,260 |
||||
Cost of revenues |
73,245 |
47,827 |
192,583 |
121,096 |
||||
Gross profit |
68,465 |
44,501 |
194,772 |
90,164 |
||||
Operating expenses: |
||||||||
Research and development |
22,648 |
17,258 |
64,150 |
49,986 |
||||
Sales and marketing |
5,726 |
4,674 |
17,192 |
12,584 |
||||
General and administrative |
9,893 |
7,165 |
29,450 |
20,839 |
||||
Restructuring |
- |
- |
- |
8,407 |
||||
Total operating expenses |
38,267 |
29,097 |
110,792 |
91,816 |
||||
Operating income (loss) |
30,198 |
15,404 |
83,980 |
(1,652) |
||||
Other income (expense): |
||||||||
Foreign currency exchange gain (loss) |
39 |
(10) |
(17) |
(1,488) |
||||
Write-down of investment |
0 |
(291) |
0 |
(291) |
||||
Interest and other income |
125 |
322 |
438 |
1,343 |
||||
Interest and other expense |
(100) |
(68) |
(416) |
(921) |
||||
Total other income (expense) - net |
64 |
(47) |
5 |
(1,357) |
||||
Income (loss) before income tax expense (benefit) |
30,262 |
15,357 |
83,985 |
(3,009) |
||||
Income tax expense (benefit) |
9,381 |
5,429 |
26,035 |
(632) |
||||
Net income (loss) |
$20,881 |
$9,928 |
$57,950 |
($2,377) |
||||
Net loss attributable to noncontrolling interest in subsidiary |
- |
857 |
148 |
2,200 |
||||
Net income (loss) attributable to Cymer, Inc. |
$20,881 |
$10,785 |
$58,098 |
($177) |
||||
Earnings (loss) per share: |
||||||||
Basic earnings (loss) per share |
$0.71 |
$0.36 |
$1.95 |
($0.01) |
||||
Weighted average common shares outstanding - basic |
29,544 |
29,762 |
29,752 |
29,697 |
||||
Diluted earnings (loss) per share |
$0.70 |
$0.36 |
$1.94 |
($0.01) |
||||
Weighted average common shares outstanding - diluted |
29,910 |
30,138 |
29,973 |
29,697 |
||||
CYMER, INC. |
||||
CONSOLIDATED BALANCE SHEETS |
||||
(in thousands) |
||||
(unaudited) |
||||
September 30, |
December 31, |
|||
2010 |
2009 |
|||
ASSETS |
||||
Current assets: |
||||
Cash and cash equivalents |
$112,036 |
$118,381 |
||
Restricted cash |
- |
1,200 |
||
Short-term investments |
65,536 |
62,895 |
||
Accounts receivable - net |
129,582 |
76,792 |
||
Accounts receivable - related party |
- |
732 |
||
Inventories |
213,046 |
185,077 |
||
Deferred and prepaid income taxes |
51,991 |
45,689 |
||
Prepaid expenses and other assets |
16,323 |
12,121 |
||
Total current assets |
588,514 |
502,887 |
||
Property and equipment - net |
106,201 |
106,755 |
||
Long-term investments |
- |
5,167 |
||
Deferred income taxes |
25,236 |
26,998 |
||
Goodwill |
8,833 |
8,833 |
||
Intangible assets - net |
7,815 |
8,327 |
||
Other assets |
5,289 |
5,951 |
||
Total assets |
$741,888 |
$664,918 |
||
LIABILITIES |
||||
Current liabilities: |
||||
Accounts payable |
$33,935 |
$21,756 |
||
Accounts payable - related party |
11 |
9,284 |
||
Accrued warranty |
11,037 |
16,640 |
||
Accrued payroll and benefits |
32,442 |
16,434 |
||
Deferred and accrued income taxes |
7,721 |
12,363 |
||
Deferred revenue |
23,326 |
22,339 |
||
Accrued and other current liabilities |
11,751 |
4,807 |
||
Total current liabilities |
120,223 |
103,623 |
||
Accrued income taxes |
14,936 |
11,562 |
||
Deferred revenue |
959 |
525 |
||
Other liabilities |
6,842 |
7,570 |
||
Total liabilities |
142,960 |
123,280 |
||
EQUITY |
||||
Cymer, Inc. stockholders' equity: |
||||
Preferred stock |
- |
- |
||
Common stock |
43 |
43 |
||
Additional paid-in capital |
611,956 |
598,314 |
||
Treasury stock at cost |
(492,890) |
(473,580) |
||
Accumulated other comprehensive loss |
(1,029) |
(8,280) |
||
Retained earnings |
480,848 |
422,750 |
||
Total Cymer, Inc. stockholders' equity |
598,928 |
539,247 |
||
Noncontrolling interest |
- |
2,391 |
||
Total equity |
598,928 |
541,638 |
||
Total liabilities and equity |
$741,888 |
$664,918 |
||
CYMER, INC. |
||||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||
(in thousands) |
||||
(unaudited) |
||||
Nine Months Ended |
||||
September 30, |
||||
2010 |
2009 |
|||
Operating activities: |
||||
Net income (loss) |
$57,950 |
($2,377) |
||
Adjustments to reconcile net income (loss) to net cash provided by |
||||
operating activities: |
||||
Depreciation, amortization and accretion |
14,747 |
16,661 |
||
Stock-based compensation |
8,036 |
3,769 |
||
Bad debt expense |
(911) |
893 |
||
Excess tax benefits from stock option exercises |
(1,519) |
(199) |
||
Provision for deferred income taxes |
(2,927) |
831 |
||
Loss on disposal or impairment of property and equipment |
132 |
1,881 |
||
Write-down of investments |
- |
291 |
||
Change in assets and liabilities: |
||||
Restricted cash |
1,265 |
(1,200) |
||
Accounts receivable |
(49,122) |
(13,920) |
||
Accounts receivable - related party |
732 |
235 |
||
Inventories |
(29,959) |
16,227 |
||
Prepaid expenses and other assets |
(3,366) |
654 |
||
Income taxes receivable |
- |
(5,036) |
||
Accounts payable |
13,659 |
1,416 |
||
Accounts payable - related party |
(9,273) |
(784) |
||
Accrued expenses and other liabilities |
17,195 |
(13,419) |
||
Deferred revenue |
1,498 |
4,516 |
||
Income taxes payable and accrued income taxes |
(1,071) |
(586) |
||
Net cash provided by operating activities |
17,066 |
9,853 |
||
Investing activities: |
||||
Acquisition of property and equipment |
(11,440) |
(7,128) |
||
Purchases of investments |
(66,008) |
(39,138) |
||
Proceeds from sold or matured investments |
68,184 |
32,363 |
||
Net cash used in investing activities |
(9,264) |
(13,903) |
||
Financing activities: |
||||
Proceeds from issuance of common stock |
4,136 |
3,771 |
||
Purchase of non-controlling interest |
(2,186) |
- |
||
Repayment of convertible subordinated note |
- |
(140,722) |
||
Cash investment in joint venture received from minority shareholder |
- |
800 |
||
Excess tax benefits from stock option exercises |
1,519 |
199 |
||
Repurchase of common stock into treasury |
(19,310) |
- |
||
Net cash used in financing activities |
(15,841) |
(135,952) |
||
Effect of exchange rate changes on cash and cash equivalents |
1,694 |
(799) |
||
Net decrease in cash and cash equivalents |
(6,345) |
(140,801) |
||
Cash and cash equivalents at beginning of the period |
118,381 |
252,391 |
||
Cash and cash equivalents at end of the period |
$112,036 |
$111,590 |
||
Supplemental disclosure of cash flow information: |
||||
Interest paid |
$259 |
$2,702 |
||
Income taxes paid |
$29,733 |
$10,157 |
||
Supplemental disclosure of non cash operating, investing and financing activities: |
||||
Net (decrease) increase in acquisition of property and equipment included in accounts payable |
($783) |
$1,253 |
||
Net (decrease) increase in in-transit proceeds from issuance of common stock |
($36) |
$195 |
||
Property and equipment acquired under capital lease obligations |
$23 |
$0 |
||
SOURCE Cymer, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article